Celecoxib improves the efficiency of the locomotor mechanism in patients with knee osteoarthritis. A randomised, placebo, double-blind and cross-over trial
Authors:
- C. DetrembleurCDC. Detrembleur
- J. De NayerJNJ. De Nayer
- A. van Den HeckeAHA. van Den Hecke
- 1 March 2005
- journal article
- clinical trial
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 13 (3) , 206-210
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Valdecoxib: A reviewClinical Therapeutics, 2003
- Efficacy of Rofecoxib, Celecoxib, and Acetaminophen in Osteoarthritis of the KneeJAMA, 2002
- Efficacy of etodolac on gait in hip osteoarthritis as assessed by Bessou's locometer: a randomized, crossover, double-blind study versus placeboOsteoarthritis and Cartilage, 2000
- Treatment of Osteoarthritis With Celecoxib, a Cyclooxygenase-2 Inhibitor: A Randomized Controlled TrialMayo Clinic Proceedings, 1999
- Data management in gait analysis for clinical applicationsClinical Biomechanics, 1998
- The 3-D motion of the centre of gravity of the human body during level walking. II. Lower limb amputeesClinical Biomechanics, 1998
- A gait analysis data collection and reduction techniqueHuman Movement Science, 1991
- The determinants of the step frequency in walking in humans.The Journal of Physiology, 1986
- The two‐period cross‐over clinical trial.British Journal of Clinical Pharmacology, 1979
- The sources of external work in level walking and running.The Journal of Physiology, 1976